Entourage Health Corp (OTCMKTS:ETRGF) (CVE:ENTG) Launches New Products: Stock Up 13% In a Week
Shares of Entourage Health Corp (OTCMKTS:ETRGF) (CVE:ENTG) are moving higher over the past week with a jump of 135.
Market Stats
On Friday, ETRGF stock fell 0.81% to $0.0735 with more than 64K shares, compared to its average volume of 190K shares. The stock moved within a range of $0.0660 – 0.0829 after opening trading at $0.0660.
Entourage Health Launches New Premium Color Cannabis Products
Canadian producer and distributor of award-winning cannabis products and brands, Entourage Health Corp (OTCMKTS:ETRGF) (CVE:ENTG) announced the expansion of Color Cannabis adult-use lineup by launching three new premium products.
The products are available in Ontario with expansion in entire Canada in quarter one in 2022. The first product is New specialty concentrate, crafted from Entourage’s award-winning cultivar, ‘Pedro’s Sweet Sativa Live Sugar’. Furthermore, new pre-roll product will include Terpene-rich cultivar ‘Black Sugar Rose’ has debuted from 18% to 24% THC 10×3.5g pre-roll pack.
Another product is part of New small-batch cultivar, is ‘Space Cake’. This has 20% to 26% THC indica-dominant hybrid available in a 3.5g.
George Scorsis, Interim CEO and Executive Chair said that the recent enhancements to cultivation programs and success of in-house growing trials broadens into the premium cannabis market.
Scorsis added that the firm is aligned with consumer preferences for consistent and innovative product flows. He added that the portfolio has been curated carefully and the result is whole flower and concentrates garnering appreciation across Canada.
The CEO added that the firm continues to strengthen the portfolio with flavoured products in 2022 as it will continue to launch additional cultivars and products nationwide.
The firm’s craft brand Royal City Cannabis Co. launched ‘RC Mango Haze Iced Hash’ as well as ‘RC Moonfire Crescent Hash’ is processed at Entourage’s solventless specialty facility in Guelph.
Key Quote
“Following the recent enhancements to our cultivation programs and success of our in-house growing trials, we are excited to confirm we are broadening into the premium cannabis market with new flower and product formats drawn from our extensive genetics bank of higher potency, terpene-rich cultivars,” said George Scorsis, Interim CEO and Executive Chair.
Traders Corner
ETRGF stock is trading above the 20-Day and 50-Day Moving averages of $0.0718 and $0.0684 respectively. However, the stock is trading below the 200-Day moving average of $0.1575.
